One of the leading medications we offer is Wegovy, the brand name for semaglutide , which is designed to help adults with obesity or those who are overweight and have at least one weight-related health condition
A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is the first of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
The problem has never been the molecule
Combination therapy may offer additive or synergistic effects, further enhancing cardiovascular and kidney protection
By helping nerve cells maintain their cytoskeletal framework, TB-500 may help prevent the permanent nerve death that often follows chronic injury [6]
By elucidating these electrophysiological features and their underlying cellular and molecular mechanisms, clinicians can more accurately assess and reduce the risk of arrhythmias in patients with ACM